Elanco Animal Health Inc
ELAN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739104
In the last 90 days, Elanco Animal Health Inc insiders filed 5 open-market purchases and 0 sales; 523 institutions reported holding it in 13F filings for Q2 2026, worth $13.9B in total; Maverick Capital is the only superinvestor holding it.
Key figures
- Insider buysLast 90 days, $1.47M in total
- 5
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +10 vs. previous quarter
- 523
- 13F valueReported value at the end of Q2 2026
- $13.9B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding ELAN, Q2 2026
1 superinvestor reports holding Elanco Animal Health Inc on Form 13F. Percentages are the stock's share of each portfolio.
Maverick Capital
Lee Ainslie
<0.1%
Elanco Animal Health Inc's share of the portfolio
- Shares
- 98,098
- Value
- $2.41M
Latest insider trades
Open-market purchases and sales by Elanco Animal Health Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 (view filing)4:16 PM ET | Aug 20 | 1 day | Kurzius Lawrence ErikDirector | PPurchase | +40.0K | $23.40 | +$935.9K | +26.9%188.6K after | |
| Aug 18, 2026 (view filing)4:32 PM ET | Aug 18 | Same day | O'Neill ShivGC AND CORP SEC | PPurchase | +4.00K | $23.58 | +$94.3K | +4.8%87.8K after | |
| Aug 13, 2026 (view filing)4:28 PM ET | Aug 12 | 1 day | Harrington Michael JDirector | PPurchase | +5.00K | $21.82 | +$109.1K | +4.0%131.5K after | |
| Aug 10, 2026 (view filing)4:14 PM ET | Aug 7 | 3 days | VanHimbergen Robert MEVP and CFO | PPurchase | +4.20K | $23.08 | +$96.9K | +3.2%137.5K after | |
| Aug 10, 2026 (view filing)4:13 PM ET | Aug 7 | 3 days | Herendeen PaulDirector | PPurchase | +10.0K | $23.69 | +$236.8K | +9.8%111.7K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Modi Rajeev A.SEE REMARKS | PPurchase | +4.91K | $20.35 | +$99.9K | +3.2%160.8K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR | PPurchase | +4.97K | $20.09 | +$99.9K | +3.0%172.0K after | |
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Kurzius Lawrence ErikDirector | PPurchase | +10.0K | $21.30 | +$213.0K | +8.2%131.8K after | |
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | Modi Rajeev A.SEE REMARKS | PPurchase | +4.50K | $21.33 | +$96.0K | +3.8%123.1K after | |
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | VanHimbergen Robert MEVP and CFO | PPurchase | +6.95K | $21.64 | +$150.4K | +5.9%124.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Elanco Animal Health Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dodge & Cox | 67,397,025 | $1.66B | 0.87% | −1,547,075−2.2% | Reduced |
| FMR LLC | 56,948,819 | $1.40B | 0.06% | +6,023,453+11.8% | Added |
| BlackRock, Inc. | 48,849,973 | $1.20B | 0.02% | +1,227,343+2.6% | Added |
| Primecap Management Co | 45,445,012 | $1.12B | 0.66% | −395,944−0.9% | Reduced |
| T. Rowe Price Investment Management, Inc. | 28,750,719 | $707.6M | 0.46% | −5,884,367−17.0% | Reduced |
| Dimensional Fund Advisors LP | 25,417,271 | $625.5M | 0.11% | +890,136+3.6% | Added |
| Vanguard Portfolio Management LLC | 22,672,312 | $558.0M | 0.03% | +34,955+0.2% | Added |
| Vanguard Capital Management LLC | 22,607,532 | $556.4M | 0.01% | +271,408+1.2% | Added |
| State Street Corp | 16,063,046 | $395.3M | 0.01% | +726,567+4.7% | Added |
| Winslow Capital Management, LLC | 13,511,127 | $332.5M | 1.14% | −103,228−0.8% | Reduced |